Buyout groups Advent, Carlyle and Avista are competing over a large stake in Italian drugs group Rottapharm, as the sale of one of Europe’s largest private equity targets moves towards a conclusion, people familiar with the situation said.
Buyout groups Advent, Carlyle and Avista are competing over a large stake in Italian drugs group Rottapharm, as the sale of one of Europe’s largest private equity targets moves towards a conclusion, people familiar with the situation said.
